Grb2 phosphorylation antagonizes EGFR-driven ras activation by interfering with condensate assembly
Upon ligand binding, the kinase domain of EGFR phosphorylates multiple tyrosine residues on the receptor cytoplasmic tail through a trans-autophosphorylation process. Phosphotyrosine sites on activated receptors recruit Grb2, which further recruits SOS to initiate downstream signaling by activating Ras. Multivalent binding between SOS and Grb2, as well as direct Grb2:Grb2 interactions, contribute to formation of a protein condensate of activated EGFR. The condensed state of EGFR facilitates autoinhibition release in SOS and exerts regulatory control over signal propagation from activated EGFR to Ras. While kinase activity of EGFR is an essential driver of this signaling process, phosphorylation at residue Y160 on Grb2 blocks Grb2:Grb2 binding and can interfere with EGFR condensation. Here, using a reconstituted system, we examine how titrating kinase activity in the EGFR system can both promote and inhibit signal output to Ras. The results reveal how effects of tyrosine kinase inhibition can, under some circumstances, promote Ras activation by inhibiting negative feedback through Grb2 phosphorylation and disruption of a Grb2 SH2/SH3 dimer interface.
Authors
- Brittany L. Stinger
- Joseph B. DeGrandchamp (ORCID: https://orcid.org/0000-0003-2194-5495)
- Jay T. Groves (ORCID: https://orcid.org/0000-0002-3037-5220)
- L. J. Nugent Lew (ORCID: https://orcid.org/0000-0002-5717-5560)
- Chun-Wei Lin (ORCID: https://orcid.org/0000-0003-1607-3987)
- Henry T. Phan (ORCID: https://orcid.org/0000-0001-7140-0480)
- Serena J. Huang
Institutions
- QB3 (US)
- Lawrence Berkeley National Laboratory (US)
- National Tsing Hua University (TW)
- University of California, Berkeley (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1371/journal.pone.0361303
- Primary Topic
- Protein Kinase Regulation and GTPase Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk
- Novo Nordisk Fonden
- National Institutes of Health